Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | J. E. Meents et al., PLOSONE January, 2017, DOI:10.1371/journal.pone.0170097 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | publication | G. Medici et al., bioRxiv preprint, 2021, doi: https://doi.org/10.1101/2021.07.26.453746 | Link | |||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., J. Pharmacol. Exp. Ther., Jan 2007; 320: 281 - 290 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | M. J. Chun et al., Oncotarget, 2016, 7 (33): 53642-53653 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene PRO | publication | S. R. Spinner, Dissertation, 2016, Technical University Munich | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | W. Eid et al., J. Cell. Biochem.,2019, 120: 8983-8991, DOI: 10.1002/jcb.28169 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | B. Trautz et al., J. Virol., Dec 2016, 90, 10915 - 10927 | |||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | R. Gil et al., Nucleic Acids Res., Oct 2013; 41: 8537 - 8545 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | S. Cabezudo et al., Nature Commun., 2021,doi.org/10.1038/s41467-021-24811-4 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | R. Berro et al., J. Virol., Jul 2008; 82: 7155 - 7166 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | C. D. Zappia et al., Scientific Reports, 2015, 5:17476, DOI: 10.1038/srep17476 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | C. Noviello et al., J. Biol. Chem., Aug 2003; 278: 31843 - 31847 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | miRNA | cotransfection (plasmid/miRNA) | K2 Transfection System | publication | Z. Cai et al., Exp. & Mol. Med., 2018, 50:45, DOI 10.1038/s12276-018-0068-3 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene PRO | publication | F. P. Martínez et al., J. Virol., Jul 2014; 88: 7389 - 7401 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/miRNA) | Metafectene | publication | S. Miretti et al., BMC Genomics, 2013, 14: 194, doi:10.1186/1471-2164-14-194 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | miRNA | RNA-Interference | K2 Transfection System | publication | V. Burghi et al., Front. Pharmacol., 2019, 10: 146, doi: 10.3389/fphar.2019.00146 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., Jul 2015; 290: 17894 - 17908 | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene PRO | publication | J. Zhao et al., 2019, US 10254283 B2 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | L. A. Chylek et al., PLoS ONE, 2014, 9(8):e104240, doi:10.1371/journal.pone.0104240 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | S. M. Figueroa, Tesis Doctoral, 2021, Universidad Complutense de Madrid | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | T. Dietschy et al., J. Cell Sci., Apr 2009; 122: 1258 - 1267 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | S. M. Hoser et al., Genome Biology, 2020, 21: 299, doi.org/10.1186/s13059-020-02199-6 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene PRO | publication | A. El Zawily et al., Scientific Reports, 2017, 7:14767, DOI:10.1038/s41598-017-15200-3 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | J.-H. Kim et al., J. of Cachexia, Sarcopenia and Muscle, 2021, 12: 177–191, DOI:10.1002/jcsm.12653 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | O. G. Engelhardt et al., J. Gen. Virol., Aug 2004; 85: 2315 - 2326 | Link |